Fizyhealth
RxFul economics

Does RxFul use pass-through drug pricing?

RxFul is not a pass-through per-vial drug pricing model in the way prescriber ordering platforms use the term. It publishes monthly SaaS tiers ($0 through $1,997/mo), bundles 3PL fulfillment on every plan, and confirms compounded medication cost during onboarding rather than on rxful.com. RxFul states there are no affiliate commission differences across tiers, but clinics still cannot see 503A drug cost separated from platform and logistics layers until onboarding quotes arrive.

This page contrasts RxFul's tiered platform-plus-fulfillment economics with pass-through per-vial pricing where drug cost is visible before checkout.

Compare Fizy Health vs RxFul

Proudly Partnered With

What pass-through pricing means — and how RxFul differs

Pass-through pricing means the 503A pharmacy's per-vial compounding cost is shown to the clinic before checkout, with platform fees disclosed separately — not folded into an opaque all-in rate. RxFul publishes platform tiers and bundles fulfillment infrastructure, which is transparent for SaaS but not for drug COGS. Medication cost is confirmed at onboarding, so clinics cannot independently verify whether any margin sits between pharmacy wholesale and the clinic price until they receive quotes. That is structurally different from a catalog where every line shows resolved 503A cost plus a named facilitation fee.

Three layers on RxFul versus two visible lines on pass-through

RxFul economics stack monthly SaaS, unpublished per-vial drug cost, and 3PL fulfillment — with volume-based fulfillment on Silver and Gold. Clinics model margin by assembling three inputs from onboarding, not by reading catalog rows. Marketing language about transparent pricing refers to published tiers, not per-vial drug transparency.

Fizy Health separates drug and platform on the screen: resolved per-vial 503A cost on each line, disclosed facilitation fee at checkout, shipping on the order row. You can verify the drug layer against your pharmacy relationship because it is visible before payment — not after a tier commitment.

When tiered SaaS beats pass-through — and when it does not

Tiered SaaS fits clinics investing in white-label patient portal infrastructure where platform features — branding, API, marketing toolkit — are the primary purchase. Pass-through fits clinics where prescribers place orders and margin depends on drug COGS clarity before the consult. The same clinic may eventually need both layers; the question is which bottleneck you are solving first.

Do not concede GLP-1 economics to any vendor without side-by-side landed cost on your top five SKUs. Headline tier savings mean nothing if per-vial semaglutide COGS is higher after onboarding.

Buy portal infrastructure — or buy drug cost visibility?

RxFul fits if

RxFul

You need white-label patient portal tiers more than prescriber drug transparency.

  • Published SaaS from $0 GLP through $1,997/mo matches your platform budget line.
  • You will confirm drug and fulfillment quotes during onboarding before patient pricing.
  • Patient-brand infrastructure is the purchase — not prescriber batch cart COGS clarity.
Consider Fizy Health if

Fizy Health

You want pass-through per-vial 503A cost before checkout.

  • Drug COGS visibility drives your margin model on GLP-1, hormone, and peptide programs.
  • You want facilitation fee named separately from 503A cost on every cart line.
  • You batch prescriber refills and need landed cost before payment, not after tier onboarding.
If you choose Fizy Health

Pass-through economics for prescriber ordering.

RxFul sells tiered portal infrastructure. Fizy Health sells visible per-vial drug cost.

See all features
Keep evaluating RxFul pricing

Related economics pages.

See the full RxFul pricing guide
FAQ

Pass-through and markup questions about RxFul.

  • Model

    Is RxFul pass-through pricing?

    RxFul publishes pass-through-style transparency on monthly SaaS tiers, not on per-vial 503A drug cost. Drug and fulfillment rates are confirmed at onboarding, not displayed in a public catalog.

  • Markup

    Does RxFul mark up compounded medications?

    RxFul does not publish per-vial rates, so clinics cannot verify markup independently. Request written 503A cost per SKU and ask whether any platform margin sits above pharmacy wholesale.

  • Affiliate

    Do affiliate commissions affect RxFul pricing?

    RxFul states no affiliate commission differences across tiers. Confirm your clinic's specific arrangement does not add rev-share on fulfillment or drug cost.

  • Fulfillment

    Is 3PL fulfillment pass-through on RxFul?

    All plans include 3PL fulfillment access. Per-shipment cost is confirmed at onboarding; Silver and Gold add volume-based fulfillment pricing that may change with order count.

  • Comparison

    How is Fizy Health pass-through different?

    Fizy Health shows resolved per-vial 503A cost on each catalog and cart line before checkout, with a disclosed facilitation fee at payment. Drug and platform fees are separate visible rows.

  • Evaluation

    What should I compare in a pass-through bake-off?

    Landed cost per vial on your top five SKUs including SaaS amortization, fulfillment, processing, and any tier commitment — on the same strengths and supply durations.

Sources reviewed June 2026

  • RxFul public website and pricing page (rxful.com/pricing), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

See pass-through per-vial cost on your formulary.

Compare 503A drug pricing before checkout — no tier gate, no onboarding quote required to browse. Free to start.

Start Ordering FreeFizy Health vs RxFul